Adult minimal-change disease: Clinical characteristics, treatment, and outcomes

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 3, 2007, Pages 445-453

  Waldman, Meryl ^a   Crew, R John ^b   Valeri, Anthony ^b   Busch, Joshua ^b   Stokes, Barry ^c   Markowitz, Glen ^c   D'Agati, Vivette ^c   Appel, Gerald ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Columbia Presbyterian ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DRUG ADMINISTRATION; DRUG RESISTANCE; FEMALE; FOLLOW UP; HUMAN; LIPOID NEPHROSIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; RECURRENCE; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 34748902200     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03531006     Document Type: Article

References (42)

1. Cameron JS: Nephrotic syndrome in the elderly. Semin Nephrol 16: 319-329, 1996
2. Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P: The nephritic syndrome in adults aged over 60: Etiology, evolution and treatment of 76 cases. Clin Nephrol 17: 232-236, 1982
3. Mak SK, Short CD, Mallick NP: Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant 11: 2192-2201, 1996
4. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG: Adult-onset minimal change nephrotic syndrome: A long-term follow-up. Kidney Int 29: 1215-1223, 1986
5. Huang JJ, Hsu SC, Chen FF, Sung JM, Tseng CC, Wang MC: Adult-onset minimal change disease among Taiwanese: Clinical features, therapeutic response, and prognosis. Am J Nephrol 21: 28-34, 2001
6. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S: Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis 39: 503-512, 2002
7. Tse KC, Lain MF, Yip PS, Li FK, Choy BY, Lai KN, Chan TM: Idiopathic minimal change nephrotic syndrome in older adults: Steroid responsiveness and pattern of relapses. Nephrol Dial Transplant 18: 1316-1320, 2003
8. Korbet SM, Schwartz MM, Lewis EJ: Minimal-change glomerulopathy of adulthood. Am J Nephrol 8: 291-297, 1988
9. Mathieson PW: Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 18[Suppl 6]: vi26-vi29, 2003
10. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98: 561-564, 1981
11. Nephrotic syndrome in children: A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children. J Pediatr 95: 239-243, 1979
12. Nair RB, Date A, Kirubakaran MG, Shastry JC: Minimal-change nephrotic syndrome in adults treated with alternate-day steroids. Nephron 47: 209-210, 1987
13. Eddy AA, Symons JM: Nephrotic syndrome in childhood. Lancet 362: 629-639, 2003
14. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS: Long-term outcome for children with minimal-change nephrotic syndrome. Lancet 1: 368-370, 1985
15. Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K: Minimal change nephrotic syndrome in adults: Response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis 17: 687-692, 1991
16. Durkan AM, Hodson EM, Willis NS, Craig JC: Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials. Kidney Int 59: 1919-1927, 2001
17. Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarte HJ: Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: Superiority of response to corticosteroid therapy over histopathologic patterns. J Pediatr 113: 996-1001, 1988
18. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft fur Padiatrische Nephrologie. Arch Intern Med 62: 1102-1106, 1987
19. Meyrier A, Noel LH, Auriche P, Callard P: Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int 45: 1446-1456, 1994
20. Tejani AT, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR: Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 33: 729-734, 1988
21. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, et al.: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8: 1326-1332, 1993
22. Meyrier A: Use of cyclosporin in the treatment of idiopathic nephrotic syndrome in adults. Contrib Nephrol 114: 28-48, 1995
23. Ponticelli C, Rizzorti G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lnsvarghi E, Gusmano R, Locatelli F, et al.: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43: 1377-1384, 1993
24. Appel GB, Radhakrishnan J, Ginzler EM: Use of mycophenolate mofetil in autoimmune and renal diseases. Transplantation 80[Suppl]: S265-S271, 2005
25. Bagga A, Hari P, Moudgil A, Jordan SC: Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42: 1114-1120, 2003
26. Pesavento TE, Bay WH, Agarwal G, Hernandez RA Jr, Hebert LA: Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy. Am J Kidney Dis 43: e3-e6, 2004
27. Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D: Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 17: 2011-2013, 2002
28. Briggs WA, Choi MJ, Scheel PJ Jr: Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31: 213-217, 1998
29. Smith JD, Hayslett JP: Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 19: 201-213, 1992
30. Lowenstein J, Schacht RG, Baldwin DS: Renal failure in minimal change nephrotic syndrome. Am J Med 70: 227-233, 1981
31. Jennette JC, Falk RJ: Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 16: 432-437, 1990
32. Ohse T, Inagi R, Tanaka T, Ota T, Miyata T, Kojima I, Ingelfinger JR, Ogawa S, Fujita T, Nangaku M: Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int 70: 1447-1455, 2006
33. Thomas ME, Brunskiil NJ, Harris KP, Bailey E, Pringle JH, Furness PN, Walls J: Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy. Kidney Int 55: 890-898, 1999
34. Wang Y, Rangan GK, Tay YC, Wang Y, Harris DC: Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 10: 1204-1213, 1999
35. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H: Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 291: F456-F464, 2006
36. Burton CJ, Combe C, Walls J, Harris KP: Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol Dial Transplant 14: 2628-2633, 1999
37. Zoja C, Benigni A, Remuzzi G: Cellular responses to protein overload: Key event in renal disease progression. Curr Opin Nephrol Hypertens 13: 31-37, 2004
38. Crew RJ, Radhakrishnan J, Appel G: Complications of the nephrotic syndrome and their treatment. Clin Nephrol 62: 245-259, 2004
39. Giangiacomo J, Cleary TG, Cole BR, Hoffsten P, Robson AM: Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome. N Engl J Med 293: 8-12, 1975
40. Spika JS, Halsey NA, Fish AJ, Lum GM, Lauer BA, Schiffman G, Giebink GS: Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics 69: 219-223, 1982
41. McLean RH, Forsgren A, Bjorksten B, Kim Y, Quie PG, Michael AF: Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res 11: 910-916, 1977
42. Idelson BA, Smithline N, Smith GW, Harrington JT: Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up. Arch Intern Med 137: 891-896, 1977